NORDIC BIOTECH INCENTIVE ApS: Financial statements 2012
CVR: 26277779
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
NORDIC BIOTECH INCENTIVE ApS (CVR 26277779) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK 7,926,490. Equity in the 2012 report amounted to DKK 8,082,643. The solvency ratio was 99.9%.
- Profit/Loss
- DKK 7,926,490
- Equity
- DKK 8,082,643
- Total Assets
- DKK 8,094,766
Official annual report
Keep an eye on NORDIC BIOTECH INCENTIVE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of July 18, 2012, KASTAN ApS is registered as an owner of NORDIC BIOTECH INCENTIVE ApS with an ownership share of 20%.
As of May 30, 2012, Christian Karsten Hansen has left the board of directors of NORDIC BIOTECH INCENTIVE ApS.
As of May 30, 2012, Florian Schønharting has left the board of directors of NORDIC BIOTECH INCENTIVE ApS.
As of May 30, 2012, Florian Schønharting is registered as director of NORDIC BIOTECH INCENTIVE ApS.
About NORDIC BIOTECH INCENTIVE ApS
NORDIC BIOTECH INCENTIVE ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Lars Grønborg Eskesen, Thue Walter Schwartz and CADENZA PARTNERS ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -397,188 and a net result of DKK -719,666 compared with DKK 4,871,034 the year before. Equity in the 2025 report amounted to DKK 5,834,302.